But Malhotra says research is still out on whether the same goes for treating sleep apnea.
6.6 Effects on renal functions The result of clinical trials of tirzepatide on kidney function indicates potential renal advantages, especially in individuals with type-2 diabetes (T2D) and a heightened cardiovascular risk.In the SURPASS-4 (NCT03730662) trial, tirzepatide was observed to reduce occurrence of the composite kidney endpoint (like eGFR decline of at least 40% from baseline, end-stage kidney disease, death due to kidney failure, or new-onset macro albuminuria) in comparison to those receiving insulin glargine
When to consider a dose increase A genuine plateau means weight loss has stopped for at least 3-4 consecutive weeks despite consistent dosing, adherence to a moderate caloric deficit, and no changes in medication or health status that could explain the stall
a study linked higher fiber intake to roughly a 10 percent drop in calories consumed
Most injection site reactions do not require treatment modification or discontinuation
At this level, appetite suppression is typically robust
